Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-011489
Filing Date
2015-02-23
Accepted
2015-02-23 17:33:53
Documents
1
Period of Report
2015-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v402177_4.html 4  
1 OWNERSHIP DOCUMENT v402177_4.xml 4 26134
  Complete submission text file 0001144204-15-011489.txt   27769
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110 617-345-3000
IPSA (INNOVEN PARTENAIRES S.A.) (Reporting) CIK: 0001620376 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 15641078